O'Fallon Erin, Gautam Shiva, D'Agata Erika M C
Hebrew Senior Life Institute for Aging Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Clin Infect Dis. 2009 May 15;48(10):1375-81. doi: 10.1086/598194.
The characteristics of colonization with multidrug-resistant gram-negative bacteria (MDRGNB) in the gastrointestinal tract have not been well defined. Characterizing the duration of colonization, clearance of colonization, and frequency of cocolonization would provide important information for the development of interventions targeting the prevention of MDRGNB spread.
From 31 October 2006 through 22 October 2007, serial rectal cultures were obtained every 3-4 weeks from residents of a long-term care facility. Clearance of colonization was defined as > or = 2 consecutive cultures from which MDRGNB were not recovered. Factors associated with clearance of colonization were analyzed using time-to-event methods.
Thirty-three patients colonized with 57 MDRGNB isolates were followed up for a median of 211 days (range, 63-356 days). Twenty (61%) of the patients were colonized with > or = 1 different MDRGNB species (median, 2 strains; range, 1-4 strains). The median duration of MDRGNB colonization was 144 days (range, 41-349 days). Clearance of colonization with all MDRGNB strains occurred in 3 patients (9%). Clearance of MDRGNB colonization, calculated by colonizing strain, occurred in 22 (39%) of 57 MDRGNB colonization episodes, with a rate of colonization clearance of 2.6 episodes per 1000 days. Clearance of multidrug-resistant Proteus mirabilis colonization occurred in 1 (6.7%) of 15 episodes, compared with clearance of 21 (50%) of 42 colonization episodes due to other MDRGNB species (hazard ratio, 0.1; 95% confidence interval, 0.01-0.78; P = .03).
Patient colonization with MDRGNB is prolonged, and a substantial proportion of patients are colonized with multiple MDRGNB species. Multidrug-resistant P. mirabilis may have a survival advantage in the gastrointestinal tract, compared with other MDRGNB species.
胃肠道中多重耐药革兰阴性菌(MDRGNB)的定植特征尚未明确。明确定植持续时间、定植清除情况以及共定植频率,将为制定预防MDRGNB传播的干预措施提供重要信息。
2006年10月31日至2007年10月22日,每隔3 - 4周从一家长期护理机构的居民中获取连续的直肠培养物。定植清除定义为连续2次或更多次培养未培养出MDRGNB。使用生存分析方法分析与定植清除相关的因素。
33例定植有57株MDRGNB分离株的患者接受了中位时间为211天(范围63 - 356天)的随访。20例(61%)患者定植有1种或更多种不同的MDRGNB菌种(中位值为2株;范围1 - 4株)。MDRGNB定植的中位持续时间为144天(范围41 - 349天)。3例患者(9%)的所有MDRGNB菌株定植均被清除。按定植菌株计算,57次MDRGNB定植事件中有22次(39%)发生了MDRGNB定植清除,定植清除率为每1000天2.6次。15次奇异变形杆菌多重耐药定植事件中有1次(6.7%)发生清除,而其他MDRGNB菌种导致的42次定植事件中有21次(50%)发生清除(风险比0.1;95%置信区间0.01 - 0.78;P = 0.03)。
患者MDRGNB定植时间延长,且相当一部分患者定植有多种MDRGNB菌种。与其他MDRGNB菌种相比,多重耐药奇异变形杆菌在胃肠道中可能具有生存优势。